𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases

✍ Scribed by M. Afshar; A.D. Martinez; R.L. Gallo; T.R. Hata

Book ID
115242739
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
258 KB
Volume
27
Category
Article
ISSN
0926-9959

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapy of hepatitis C: Re-treatment wit
Therapy of hepatitis C: Re-treatment with alpha interferon
✍ A Alberti; L Chemello; F Noventa; L Cavalletto; GianLuca De Salvo πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 2 views

The long-term benefit of interferon therapy in chronic hepatitis C is limited. During therapy, serum alanine aminotransferase (ALT) levels decrease to normal and hepatitis C virus (HCV) RNA decreases in 40% to 60% of patients. However, most patients relapse after therapy withdrawal, so that no more

Analysis of clinical and virological fac
Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C
✍ Dr. J. A. Garson; K. Whitby; R. Deaville; S. Brillanti; M. Foli; C. Masci; M. Mi πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 508 KB

## Abstract Interferon alpha (IFN‐α) therapy is currently the treatment of choice for chronic hepatitis C (HCV) infection, but it fails to achieve a sustained response in approximately 75% of those treated. The factors which determine whether or not an individual will respond to IFN‐α are uncertain